Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 128 | 267 | 183 | 371 | 702 |
| Gross Profit | 128 | 267 | 183 | 371 | 702 |
| Operating Expenses | 1,122 | 1,168 | 3,207 | 3,373 | 3,535 |
| Operating Income | -994 | -901 | -3,024 | -3,002 | -2,833 |
| Interest Expense | -1 | 1 | 211 | -25 | 158 |
| Other Income | -617 | 61 | 15 | 15 | 15 |
| Pre-tax Income | -1,611 | -840 | -3,219 | -2,962 | -2,976 |
| Net Income Continuous | -1,611 | -840 | -3,219 | -2,962 | -2,976 |
| Net Income Discontinuous | 15,851 | -2,689 | N/A | N/A | N/A |
| Net Income | $14,240 | $-3,529 | $-3,219 | $-2,962 | $-2,976 |
| EPS Basic Total Ops | 17.25 | -4.12 | -7.99 | -0.20 | -5.34 |
| EPS Basic Continuous Ops | -1.97 | -1.03 | -8.72 | -0.23 | -4.95 |
| EPS Basic Discontinuous Ops | 19.35 | -3.31 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 10.62 | -4.12 | -7.99 | -0.20 | -5.34 |
| EPS Diluted Continuous Ops | -1.15 | -1.03 | -8.72 | -0.23 | -4.95 |
| EPS Diluted Discontinuous Ops | 11.33 | -3.31 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.77 | -1.37 | -4.06 | -4.07 | -5.00 |
| EBITDA(a) | $-873 | $-820 | $-2,940 | $-2,914 | $-2,747 |